SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community debate after a massive, rapid sell-off triggered by allegations of market manipulation and insider dumping. While some traders are attempting to scalp the token during its sharp decline, others remain deeply skeptical, comparing the rapid price cycle to previous high-profile crypto project collapses.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to a major expansion in its partnership with NVIDIA to integrate QNX safety-certified software into industrial, medical, and robotics edge AI platforms. The community is buzzing with optimism, with many long-term shareholders viewing this as a pivotal validation of the company's turnaround and its transition into a key player for physical AI and autonomous systems.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is undergoing a massive, mechanical short squeeze driven by a highly concentrated ownership structure that has effectively locked the float and left short sellers with little room to exit. The community is actively debating the sustainability of this parabolic move, with many traders warning of an inevitable and sharp correction while others point to the lack of available shares to borrow as fuel for further upside.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending as retail sentiment surges following the termination of a dilutive equity facility and regulatory approval to remove pattern day trading restrictions. The community is actively discussing a potential short squeeze, citing significant institutional interest and price momentum as the stock moves toward key breakout levels.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is trending as investors react to a government executive order aimed at expediting the review of psychedelic treatments, including ibogaine. The community is actively debating the company's ability to capitalize on this news, with bulls pointing to their GMP-compliant supply chain and potential pipeline, while bears remain skeptical about the firm's history of dilution and long-term financial viability.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is surging as investors cheer a surprise return to profitability, strong revenue growth, and the strategic integration of Stereolabs to bolster its 'Physical AI' perception stack. The company is gaining momentum through significant software-attached contract wins in smart infrastructure and defense, with the market actively weighing the long-term potential of these recurring revenue streams against broader macroeconomic volatility.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is surging as investors closely monitor positive clinical trial results for its autoimmune CAR-T pipeline, specifically focusing on miv-cel's potential as a first-in-class treatment. The community is actively debating the company's valuation, recent institutional accumulation, and the increasing likelihood of an acquisition by a larger pharmaceutical player as it advances its registrational trials.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased volatility and investor interest following a better-than-expected Medicare Advantage rate announcement from CMS, which has alleviated regulatory concerns. The community is actively debating whether this news marks a structural recovery and an opportunity for a breakout, or if the stock remains vulnerable to further downside and potential volatility ahead of upcoming earnings.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is surging following positive clinical trial data and strong market sentiment regarding the psychedelic sector's regulatory future, with the community closely tracking the potential for FDA priority review vouchers. Traders are actively debating the company's competitive advantage in treatment-resistant depression while monitoring the stock's high volatility and the potential impact of sector-wide policy catalysts.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Cronos ($CRO) is experiencing intense community debate over its reissuance schedule and potential for long-term growth, with investors divided between concerns over supply dilution and hopes for institutional catalysts like potential ETFs. While some community members are frustrated by the token's stagnant price action relative to the broader market, others are actively accumulating positions and promoting ecosystem meme coins like $CAW and $MERY as speculative plays on the chain's future activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
